Prevalence of Parkinson's disease across North America

NPJ Parkinson's Disease
C MarrasParkinson’s Foundation P4 Group

Abstract

Estimates of the prevalence of Parkinson's disease in North America have varied widely and many estimates are based on small numbers of cases and from small regional subpopulations. We sought to estimate the prevalence of Parkinson's disease in North America by combining data from a multi-study sampling strategy in diverse geographic regions and/or data sources. Five separate cohort studies in California (2), Minnesota (1), Hawaii USA (1), and Ontario, Canada (1) estimated the prevalence of PD from health-care records (3), active ascertainment through facilities, large group, and neurology practices (1), and longitudinal follow-up of a population cohort (1). US Medicare program data provided complementary estimates for the corresponding regions. Using our age- and sex-specific meta-estimates from California, Minnesota, and Ontario and the US population structure from 2010, we estimate the overall prevalence of PD among those aged ≥45 years to be 572 per 100,000 (95% confidence interval 537-614) that there were 680,000 individuals in the US aged ≥45 years with PD in 2010 and that that number will rise to approximately 930,000 in 2020 and 1,238,000 in 2030 based on the US Census Bureau population projections. Regional variations ...Continue Reading

References

Jun 1, 1986·Archives of Neurology·B S SchoenbergA F Haerer
Jan 1, 1994·Neuroepidemiology·S MoghalR Rajput
Jan 1, 1995·Neuroepidemiology·S MoghalR Rajput
Mar 1, 1996·Mayo Clinic Proceedings·L J Melton
Jul 12, 2002·Statistics in Medicine·Julian P T Higgins, Simon G Thompson
Mar 7, 2003·Movement Disorders : Official Journal of the Movement Disorder Society·Mark GuttmanC David Naylor
Jun 5, 2003·American Journal of Epidemiology·Stephen K Van Den EedenLorene M Nelson
Sep 6, 2003·BMJ : British Medical Journal·Julian P T HigginsDouglas G Altman
Jan 31, 2007·Statistical Methods in Medical Research·Ram C TiwariZhaohui Zou
Aug 15, 2009·Journal of Epidemiology and Community Health·Lisa M LixShaun Hobson
Aug 16, 2012·Movement Disorders : Official Journal of the Movement Disorder Society·Paul H GordonJames E Cheek
Jul 1, 2014·Movement Disorders : Official Journal of the Movement Disorder Society·Tamara PringsheimThomas D L Steeves
Jun 21, 2016·JAMA Neurology·Rodolfo SavicaWalter A Rocca
Aug 23, 2016·The Permanente Journal·Nancy Gordon, Teresa Lin
Jun 8, 2017·Movement Disorders : Official Journal of the Movement Disorder Society·Alexander RossiXuemei Huang
Aug 27, 2017·Movement Disorders : Official Journal of the Movement Disorder Society·Pierpaolo TurcanoRodolfo Savica

❮ Previous
Next ❯

Citations

Oct 5, 2018·Current Neurology and Neuroscience Reports·S L SisonA D Ebert
Dec 28, 2018·Movement Disorders : Official Journal of the Movement Disorder Society·Pablo Martinez-MartinKavita Sail
May 16, 2019·Journal of Medical Engineering & Technology·Abhishek MahajanNeelesh Kumar
Nov 17, 2019·Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists·Blair N HonseyKathryn A Wyman-Chick
May 31, 2019·Movement Disorders : Official Journal of the Movement Disorder Society·John D HeissKrystof S Bankiewicz
Feb 12, 2020·JAMA : the Journal of the American Medical Association·Melissa J Armstrong, Michael S Okun
Apr 8, 2020·Acta Neurologica Scandinavica·Brenda JengRobert W Motl
Apr 21, 2020·Journal of Parkinson's Disease·Chunsong JiaTongwen Ou
May 14, 2020·Physiotherapy Theory and Practice·Peter C DourisJoanne DiFrancisco-Donoghue
May 20, 2020·Expert Review of Neurotherapeutics·Aristide MerolaKrzysztof Bankiewicz
Jul 8, 2020·Journal of Neuroscience Research·Vania Macías-CalvioMaría-Paz Marzolo
Mar 25, 2020·Aging·Jack KellyXinzhong Li
Aug 29, 2020·Molecular Genetics & Genomic Medicine·Nguyen Dang TonNong Van Hai
Sep 24, 2020·Occupational Therapy in Health Care·Laura A SwinkArlene A Schmid
Oct 5, 2020·Brain : a Journal of Neurology·Ruth BrauerTom Foltynie
May 16, 2019·Movement Disorders : Official Journal of the Movement Disorder Society·Connie MarrasSamuel M Goldman
Feb 15, 2020·Protein Science : a Publication of the Protein Society·Emily L EberhardtMichael A Cianfrocco
Jun 2, 2020·Biomedical Engineering Letters·Afzal Hussain Shahid, Maheshwari Prasad Singh
May 3, 2020·International Journal of Molecular Sciences·Harris BolusStanislava Chtarbanova
Sep 26, 2020·Experimental & Molecular Medicine·Rachael H Earls, Jae-Kyung Lee
Mar 7, 2019·Biochemical Society Transactions·Jillian H KlussMark R Cookson
May 18, 2020·Journal of Parkinson's Disease·Meagan BaileyDeborah A Hall
Sep 17, 2020·BMC Medical Informatics and Decision Making·Ibrahim KarabayirOguz Akbilgic
Mar 8, 2019·Journal of Applied Physiology·Tiffany J GlassMichelle R Ciucci
Apr 9, 2020·Acta Neuropathologica Communications·Vedad DelicBruce A Citron
Dec 25, 2019·Behavioural Neurology·Erin R SmithTeresita Villaseñor
Aug 21, 2019·Frontiers in Neurology·Floris Pieter VlaanderenMarjan J Meinders
Nov 7, 2019·Oxidative Medicine and Cellular Longevity·Dinendra L Abeyawardhane, Heather R Lucas
Dec 24, 2019·Frontiers in Cell and Developmental Biology·Yoo Jin JungNigel H Greig
Jul 16, 2020·NPJ Parkinson's Disease·Wenya YangTed Thompson
Apr 26, 2020·Journal of Parkinson's Disease·Julia L Y CheongAlastair J Noyce

❮ Previous
Next ❯

Software Mentioned

metafor
R

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.